Literature DB >> 12444227

Does a preexisting anxiety disorder predict response to paroxetine in irritable bowel syndrome?

Prakash S Masand1, Sanjay Gupta, Thomas L Schwartz, David Kaplan, Subhdeep Virk, Ahmad Hameed, Kari Lockwood.   

Abstract

Irritable bowel syndrome (IBS) is the most common disorder in patients seen by gastroenterologists. Twenty subjects with IBS diagnosed with the Rome criteria were treated for 12 weeks with 20-40 mg/day of paroxetine (mean dose=31 mg/day). At baseline, 10 patients had a lifetime history of an anxiety disorder, and 10 patients did not have such a history. Both groups had similar improvement in abdominal pain, constipation, diarrhea, incomplete emptying, and bloating/ abdominal distension. Paroxetine was very well tolerated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12444227     DOI: 10.1176/appi.psy.43.6.451

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  4 in total

1.  Paroxetine for somatic pain associated with physical illness: a review.

Authors:  Prakash S Masand; Meera Narasimhan; Ashwin A Patkar
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

2.  Open-label treatment with citalopram in patients with irritable bowel syndrome: a pilot study.

Authors:  Prakash S Masand; Sanjay Gupta; Thomas L Schwartz; Subhdeep Virk; Ahmad Hameed; David S Kaplan
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

Review 3.  The interface of psychiatry and irritable bowel syndrome.

Authors:  David G Folks
Journal:  Curr Psychiatry Rep       Date:  2004-06       Impact factor: 5.285

Review 4.  Effects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseases.

Authors:  Madhusudan Grover; Michael Camilleri
Journal:  J Gastroenterol       Date:  2012-12-20       Impact factor: 7.527

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.